vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $57.1M, roughly 1.1× NETSTREIT Corp.). NETSTREIT Corp. runs the higher net margin — 10.0% vs -70.9%, a 80.9% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs 8.1%). Over the past eight quarters, NETSTREIT Corp.'s revenue compounded faster (20.1% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
CTKB vs NTST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $57.1M |
| Net Profit | $-44.1M | $5.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 34.1% |
| Net Margin | -70.9% | 10.0% |
| Revenue YoY | 8.1% | 24.3% |
| Net Profit YoY | -557.1% | 235.9% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.1M | ||
| Q4 25 | $62.1M | $52.5M | ||
| Q3 25 | $52.3M | $48.3M | ||
| Q2 25 | $45.6M | $48.3M | ||
| Q1 25 | $41.5M | $45.9M | ||
| Q4 24 | $57.5M | $44.1M | ||
| Q3 24 | $51.5M | $41.4M | ||
| Q2 24 | $46.6M | $39.6M |
| Q1 26 | — | $5.7M | ||
| Q4 25 | $-44.1M | $1.3M | ||
| Q3 25 | $-5.5M | $618.0K | ||
| Q2 25 | $-5.6M | $3.3M | ||
| Q1 25 | $-11.4M | $1.7M | ||
| Q4 24 | $9.6M | $-5.4M | ||
| Q3 24 | $941.0K | $-5.3M | ||
| Q2 24 | $-10.4M | $-2.3M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | 34.1% | ||
| Q4 25 | -9.0% | 2.6% | ||
| Q3 25 | -17.6% | 1.3% | ||
| Q2 25 | -23.3% | 6.8% | ||
| Q1 25 | -36.1% | 3.7% | ||
| Q4 24 | 5.2% | -12.3% | ||
| Q3 24 | -8.2% | -12.8% | ||
| Q2 24 | -18.3% | -5.8% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | -70.9% | 2.5% | ||
| Q3 25 | -10.5% | 1.3% | ||
| Q2 25 | -12.2% | 6.8% | ||
| Q1 25 | -27.5% | 3.7% | ||
| Q4 24 | 16.8% | -12.3% | ||
| Q3 24 | 1.8% | -12.8% | ||
| Q2 24 | -22.4% | -5.8% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.02 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $1.5B |
| Total Assets | $461.5M | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $926.6M | ||
| Q1 25 | — | $913.3M | ||
| Q4 24 | — | $868.3M | ||
| Q3 24 | — | $778.7M | ||
| Q2 24 | — | $726.2M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $341.7M | $1.4B | ||
| Q3 25 | $378.6M | $1.3B | ||
| Q2 25 | $377.6M | $1.3B | ||
| Q1 25 | $379.6M | $1.3B | ||
| Q4 24 | $395.7M | $1.3B | ||
| Q3 24 | $385.5M | $1.3B | ||
| Q2 24 | $389.1M | $1.3B |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $461.5M | $2.6B | ||
| Q3 25 | $494.9M | $2.5B | ||
| Q2 25 | $493.3M | $2.3B | ||
| Q1 25 | $482.6M | $2.3B | ||
| Q4 24 | $499.5M | $2.3B | ||
| Q3 24 | $491.2M | $2.2B | ||
| Q2 24 | $483.7M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $109.5M | ||
| Q3 25 | $-3.9M | $28.0M | ||
| Q2 25 | $108.0K | $30.6M | ||
| Q1 25 | $-125.0K | $22.1M | ||
| Q4 24 | $2.0M | $90.2M | ||
| Q3 24 | $13.2M | $25.1M | ||
| Q2 24 | $6.2M | $25.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 82.46× | ||
| Q3 25 | — | 45.27× | ||
| Q2 25 | — | 9.36× | ||
| Q1 25 | — | 13.06× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
